Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials Network
- Lori J. Ducharme(corresponding author),
- Hannah K. Knudsen,
- Paul M. Roman,
- University of Georgia
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewSustainable Development Goals
- SDG 3 Good Health and Well
Abstract
<p>Researchers and policymakers are increasingly focusing on factors that facilitate or impede the diffusion of evidence-based treatment techniques into routine clinical practice. One potentially fruitful avenue of research is the influence of involvement in research networks as a predictor of organizational innovation. The Clinical Trials Network (CTN) is examining a number of behavioral and pharmacological treatment techniques in controlled multisite studies. Using data from participating CTN treatment programs and large samples of programs outside the CTN, these analyses examine the influence of exposure to clinical trials on the subsequent adoption of buprenorphine and voucher-based motivational incentives. The analyses show that, controlling for a variety of organizational characteristics, direct exposure to buprenorphine clinical trials in the CTN significantly increased the odds of subsequent adoption. By contrast, the adoption of motivational incentives was entirely explained by organizational characteristics. The findings suggest that adoption of treatment innovations is a function of exposure, organizational resources, nature of innovations, and stage of the diffusion process.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 321-329 (9 pages)Journal (Volume, Issue Number)
Journal of Substance Abuse Treatment (Volume 32, Issue 4)Publication milestones
- Published - 06/2007
Publication status
Published - 06/2007
ISSN
0740-5472Publication IDs
- Scopus: 34247546059
- PubMed: 17481455
- ORCID: /0000-0002-3150-2199/work/67683833
Publication metrics
Metrics
SciVal
citations
87
SciVal
FWCI
4.17
SciVal
Author count
4
SciVal
Paper percentile
94
SciVal
Top percentile
10
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Citation count
97
Mentions
1
Social media
3
Captures
90
Funding Details
The authors gratefully acknowledge the support of research grants R01DA13110 and R01DA14482 from the NIDA. The opinions expressed here are those of the authors and do not represent the official position of the NIDA.
FunderFunding number
NIDA
R01DA014482
